Reuters Health Report

Click to View in Browser 09/11/2014 Nigeria checking South African national as suspected Ebola case LAGOS (Reuters) - Nigerian health authorities said on Thursday they were holding for Ebola testing a South African national in transit to her country because she was showing potential symptoms of the disease after working in Guinea and Sierra Leone. What cancer patients want and what Medicare covers may differ NEW YORK (Reuters Health - When asked what Medicare should cover for cancer patients in their last months of life, many patients and their caregivers choose benefits the federal insurance does not offer, like home-based long term care and concurrent palliative care, according to a new study based on interviews. Man pleads not guilty to fraud in 2012 U.S. meningitis outbreak BOSTON (Reuters) - The first person to face criminal charges linked to a 2012 U.S. meningitis outbreak that killed 64 people and sickened 700 in 20 states pleaded not guilty on Thursday to claims that he knowingly shipped a tainted medication. Long-awaited diet pill gets U.S. approval (Reuters) - A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration. Cancer-zapping proton therapy only suitable for rare patients LONDON, Sept 11 (Reuters) - A new cancer-zapping therapy for which a British couple took their child to the Czech Republic amid an international police hunt and media storm can be highly effective, experts say, but is only suitable for rare tumors. U.S. hearing aid sales dip in August COPENHAGEN (Reuters) - U.S. hearing aid sales dipped in August from a year ago, as a drop in the private market was cushioned by sales to army veterans, data from the Hearing Industries Association showed on Thursday. Ebola highlights slow progress in war on tropical diseases LONDON (Reuters) - Some of the world's most gruesome diseases are finally getting a bit of attention. U.S. FDA staff review of NPS drug sparks stock rebound WASHINGTON (Reuters) - Shares in NPS Pharmaceuticals Inc soared on Wednesday after a preliminary report from U.S. regulators said its hormone replacement therapy Natpara, which could be approved by late next month, appears to be effective. Sanofi aims to grow Genzyme unit with new drugs and acquisitions PARIS (Reuters) - Sanofi rare disease unit Genzyme hopes to become a leader in the multiple sclerosis (MS) field with the help of new products developed in-house but also through acquisitions, senior Genzyme executives told Reuters. Missouri lawmakers override Governor's veto on '72-hour' abortion law (Reuters) - Missouri lawmakers on Wednesday passed a law requiring women to wait three days for an abortion, even in cases of rape or incest, according to the legislature's websites - overriding an earlier veto from Governor Jay Nixon, Related Video Bacteria-treated honey cures wounds and offers antibiotic resistance hope Climate change increases possibility of megadrought in Southwestern U.S. The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend